Degarelix | High Purity Peptide | CAS No. 214766-78-6

Degarelix | High Purity Peptide | CAS No. 214766-78-6

Degarelix (CAS No. 214766-78-6) is a synthetic decapeptide and a potent gonadotropin-releasing hormone (GnRH) receptor antagonist. By competitively binding to GnRH receptors in the pituitary gland, Degarelix rapidly suppresses the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a rapid decrease in testosterone levels.
Send Inquiry
Description

Product Introduction

 

Degarelix (CAS No. 214766-78-6) is a synthetic decapeptide and a potent gonadotropin-releasing hormone (GnRH) receptor antagonist. By competitively binding to GnRH receptors in the pituitary gland, Degarelix rapidly suppresses the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a rapid decrease in testosterone levels. It is clinically used for the treatment of advanced prostate cancer, providing an alternative to traditional GnRH agonists with faster onset and reduced testosterone flare. Our Degarelix is produced using advanced solid-phase peptide synthesis (SPPS) and high-purity HPLC purification, ensuring batch-to-batch consistency, high stability, and suitability for pharmaceutical development and biomedical research.

 

Product Parameters (Specification)

 

Parameter

Specification

Product Name

Degarelix

CAS No.

214766-78-6

Molecular Formula

C82H116N18O16

Molecular Weight

~1625.0 g/mol

Appearance

White to off-white lyophilized powder

Purity (HPLC)

≥98%

Storage

Store at -20°C, protected from light and moisture

Shelf Life

2 years under proper storage conditions

 

Product Features and Applications

 

  • High-purity peptide synthesized using SPPS technology.
  • Potent GnRH receptor antagonist, rapidly reducing testosterone levels.
  • Clinically used in the treatment of advanced prostate cancer.
  • Suitable for pharmaceutical research, drug development, and reference standard studies.
  • Applicable for injectable formulations and preclinical prostate cancer studies.

 

Production Details

 

Degarelix is produced in GMP-compliant facilities using SPPS followed by HPLC purification and lyophilization. Each batch undergoes rigorous analytical testing including HPLC, MS, amino acid sequencing, optical rotation, moisture content, and solvent residue to ensure identity, purity, and consistency.

 

Product Qualification

 

Our manufacturing facilities are ISO9001 and GMP certified. All peptide products are provided with comprehensive documentation including Certificate of Analysis (COA), MSDS, and analytical data. Third-party testing reports are available upon request.

 

Delivery, Shipping, and Service

Packaging

1mg, 5mg, 10mg, or customized sizes upon request.

Lead Time

Typically 3–5 business days after order confirmation.

Shipping

Express delivery via DHL, FedEx, or UPS with cold-chain protection.

Customer Service

Dedicated technical and after-sales support team available 24/7.

 

FAQ

 

Q1: Is Degarelix for human use?

A: For research and pharmaceutical manufacturing use only, not for direct human administration.

Q2: How should Degarelix be stored?

A: Keep in a tightly sealed vial at -20°C, protected from moisture and light.

Q3: Can analytical data be provided?

A: Yes, COA, HPLC, and MS data accompany each batch shipment.

 

Latest News

 

We continuously invest in R&D for peptide synthesis and formulation technologies, ensuring the highest quality standards for our pharmaceutical-grade peptides. For more peptide innovations, please visit our official website.

 

Hot Tags: degarelix | high purity peptide | cas no. 214766-78-6, China degarelix | high purity peptide | cas no. 214766-78-6 manufacturers, suppliers